Association of red blood cell transfusion and postoperative outcomes after endovascular aortic repair

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 15, Issue 1-2, 2011, Pages 49-55

  Argalious, Maged Y ^a   Dalton, Jarrod E ^a   Mascha, Edward J ^a   Cywinski, Jacek B ^a   Clair, Daniel G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Inflammation; Outcomes; Postoperative complications

Indexed keywords

AGED; ARTICLE; ENDOVASCULAR ANEURYSM REPAIR; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PROPENSITY SCORE; TREATMENT OUTCOME;

AORTA; ERYTHROCYTE TRANSFUSION; HUMANS; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 80054858037     PISSN: 10892532     EISSN: 19405596     Source Type: Journal    
DOI: 10.1177/1089253211410714     Document Type: Article

References (27)

1. Chahwan S, Comerota AJ, Pigott JP, Scheuermann BW, Burrow J, Wojnarowski D. Elective treatment of abdominal aortic aneurysm with endovascular or open repair. J Vasc Surg. 2007;45:258-262. (Pubitemid 46149982)
2. Prinssen M, Verhoeven EL, Buth J, et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2004;351:1607-1618. (Pubitemid 39350421)
3. Kaviani A, Greenberg R. Current status of branched stent-graft technology in treatment of thoracoabdominal aneu-rysms. Semin Vasc Surg. 2006;19:60-65.
4. Greenberg RK, West K, Pfaff K, et al. Beyond the aortic bifurcation: branched endovascular grafts for thoracoab-dominal and aortoiliac aneurysms. J Vasc Surg. 2006;43: 879-886.
5. Fransen E, Maessen J, Dentener M, Senden N, Buurman W. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest. 1999;116: 1233-1239. (Pubitemid 29535973)
6. Koch CG, Li L, Duncan AI, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg. 2006;81:1650-1657. (Pubitemid 350030027)
7. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood trans-fusion in critically ill patients. JAMA. 2002;288: 1499-1507.
8. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: anemia and blood transfusion in the critically ill\-current clinical practice in the United States. Crit Care Med. 2004; 32:39-52. (Pubitemid 38125561)
9. Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating and prothrombotic properties of ane-mia and red blood cell transfusion. J Thromb Thrombolysis. 2006;21:167-174.
10. Brandstrup B, Tonnesen H, Beier-Holgersen R, et al. Effects of intravenous fluid restriction on postoperative complica-tions: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg. 2003;238:641-648. (Pubitemid 38182252)
11. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac sur-gery patients. Mayo Clin Proc. 2005;80:862-866. (Pubitemid 40911459)
12. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion require-ments in critical care. N Engl J Med. 1999;340:409-417. (Pubitemid 29084771)
13. Vincent JL, Sakr Y, LeGall JR, et al. Is red blood cell trans-fusion associated with worse outcome? Results of the SOAP study. Chest. 2003;124:125S-126S.
14. Carson JL, Duff A, Berlin JA, et al. Perioperative blood trans-fusion and postoperative mortality. JAMA. 1998;279: 199-205. (Pubitemid 28133781)
15. Hill SR, Carless PA, Henry DA, et al. Transfusion thresholds and other strategies for guiding allogenic red blood cell trans-fusion. Cochrane Database Syst Rev. 2002;(2):CD002042. doi: 10.1002/14651858.CD002042.pub2.
16. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345:1230-1236. (Pubitemid 34951486)
17. Koch CG, Li L, Duncan AI, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:1608-1616. (Pubitemid 43810038)
18. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood. 2001;97:1180-1195. (Pubitemid 32183738)
19. Fergusson D, Khanna MP, Tinmouth A, Herbert PC Transfu-sion of leukoreduced red blood cells may decrease postopera-tive infections: two meta-analyses of randomized controlled trials. Can J Anaesth. 2004;51:417-424.
20. Herbert PC, Fergusson D, Blajchman MA, et al. Clinical out-comes following institution of the Canadian universal leu-koreduction program for red blood cell transfusions. JAMA. 2003;289:1941-1949. (Pubitemid 37430225)
21. Blajchman MA. Immunomodulation and blood transfusion. Am J Ther. 2002;9:389-395.
22. Klein HG. Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology. 1999;91:861-865. (Pubitemid 29418669)
23. Rowlands TE, Homer-Vanniasinkam S. Pro- and anti-inflammatory cytokine release in open versus endovas-cular repair of aortic aneurysm. Br J Surg. 2001;88: 1335-1340. (Pubitemid 32955412)
24. Hebert PC, Wells G, Tweeddale M, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med. 1997;155:1618-1623.
25. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity Lancet. 1996;348:1055-1060. (Pubitemid 26343599)
26. Spiess BD, Royston D, Levy JH, et al. Platelet transfusions during coronary artery bypass grafting are associated with worse outcomes. Transfusion. 2004;44:1143-1148. (Pubitemid 38989746)
27. Karkouti K, Wijeysundera DN, Yau TM, et al. Platelet transfu-sions are not associated with increased morbidity or mortality in cardiac surgery. Can J Anesth. 2006;53:279-287.